Www.youtor.org Youtor


Search Videos By URL

Glofitamab (updated 2024-10-24)

Glofitamab stepup dosing in RR MCL [upl. by Oivalf]
Duration: 3:16
154 weergaven | 7 jan. 2022
Phase II study of glofitamab in patients with RR LBCL [upl. by Kimmy16]
Duration: 2:40
462 weergaven | 14 jun. 2022
Laufzeit einer Infusion [upl. by Htebazie163]
Duration: 0:45
21,9K weergaven | 3 okt. 2021
Bispecific antibodies for nonHodgkin lymphoma [upl. by Treacy]
Duration: 2:43
494 weergaven | 19 jun. 2020
Current treatment options and emerging strategies in MCL [upl. by Zsa]
Duration: 3:44
264 weergaven | 24 mei 2022
Dr Battiwalla on the Expanding Use of Bispecific Antibodies in NHL [upl. by Ulric]
Duration: 3:04
47 weergaven | 3 weken geleden
The current immunotherapeutic landscape for treatment of DLBCL [upl. by Wendie]
Duration: 1:53
168 weergaven | 9 maanden geleden
Glofitamab and obinutuzumab in rr MCL [upl. by Morgenthaler370]
Duration: 5:44
375 weergaven | 11 dec. 2021
The role of epcoritamab in thirdline or later LBCL [upl. by Nylodnarb]
Duration: 3:09
849 weergaven | 28 jul. 2023
Emerging lymphoma therapies bispecific antibodies and CAR Tcells [upl. by Tyree]
Duration: 2:29
107 weergaven | 2 feb. 2021
Redtalks s3e5 Combining glofitamab with costimulatory bispecifics [upl. by Ahsurej392]
Duration: 1:20:30
44 weergaven | 9 maanden geleden
Updated efficacy data on glofitamab stepup dosing in NHL [upl. by Thanasi248]
Duration: 2:18
143 weergaven | 22 jun. 2021
Preliminary results from NP40126 Glofitamab and RCHOP in NHL [upl. by Concoff]
Duration: 1:43
246 weergaven | 2 feb. 2022
The benefits of glofitamab in RR DLBCL postCART therapy [upl. by Eornom]
Duration: 1:15
775 weergaven | 28 jul. 2023
Understanding your treatment Rituxan antibody therapy [upl. by Salb253]
Duration: 17:59
150,5K weergaven | 29 apr. 2013
NP30179 Glofitamab monotherapy in RR NHL [upl. by Rosecan]
Duration: 0:50
115 weergaven | 2 feb. 2022



New on site
Content Report
youtor.org / Youtor Videos converter © 2024

5